Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-221211
Filing Date
2011-08-12
Accepted
2011-08-12 15:10:56
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 310010
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6200
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6172
4 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5369
  Complete submission text file 0001193125-11-221211.txt   1371628

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dara-20110630.xml EX-101.INS 111452
6 XBRL TAXONOMY EXTENSION SCHEMA dara-20110630.xsd EX-101.SCH 14784
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dara-20110630_cal.xml EX-101.CAL 42593
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dara-20110630_lab.xml EX-101.LAB 128118
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dara-20110630_pre.xml EX-101.PRE 83449
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23776 | Film No.: 111031030
SIC: 2834 Pharmaceutical Preparations